References
- Brand CU, Ellwanger U, Stroebel W, Meier F, Schlagenhauff B, Rassner G, . Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors. Cancer 1997;79:2345–53.
- Manola J, Atkins M, Ibrahim J, Kirkwood J. Prognostic factors in metastatic melanoma: A pooled analysis of Eastern Cooperative Oncology Group trials. J Clin Oncol 2000;18:3782–93.
- Petersen RP, Hanish SI, Haney JC, Miller CC, 3rd, Burfeind WR, Jr., Tyler DS, . Improved survival with pulmonary metastasectomy: An analysis of 1720 patients with pulmonary metastatic melanoma. [see comment]. J Thorac Cardiovasc Surg 2007;133:104–10.
- Yan TD, King J, Sjarif A, Glenn D, Steinke K, Morris DL. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: Prognostic determinants for survival. Ann Surg Oncol 2006;13:1529–37.
- Leo F, Cagini L, Cappello M, Van Geel AN, Maggi G, Goldstraw P, . Lung metastases from melanoma: When is surgical treatment warranted? Br J Cancer 2000; 83:569–72.